Shanghai Sanyou Medical Co., Ltd (SHA:688085)
20.53
-0.18 (-0.87%)
Mar 9, 2026, 3:00 PM CST
Shanghai Sanyou Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 403.09 | 654.35 | 340.43 | 382.31 |
Short-Term Investments | - | 234.84 | - | - | - |
Trading Asset Securities | - | 50.23 | 19.63 | 193.1 | 376.63 |
Cash & Short-Term Investments | 556.49 | 688.16 | 673.98 | 533.53 | 758.94 |
Cash Growth | -19.13% | 2.10% | 26.32% | -29.70% | -33.61% |
Accounts Receivable | - | 73.14 | 61.53 | 275.37 | 252.88 |
Other Receivables | - | 3.98 | 0.94 | 2.75 | 2.4 |
Receivables | - | 77.12 | 62.46 | 278.12 | 255.29 |
Inventory | - | 246.11 | 176.66 | 155.08 | 121.48 |
Other Current Assets | - | 22.25 | 33.19 | 27.68 | 14.91 |
Total Current Assets | - | 1,034 | 946.3 | 994.41 | 1,151 |
Property, Plant & Equipment | - | 346.58 | 344.09 | 345.42 | 256.31 |
Long-Term Investments | - | 426.39 | 490.05 | 425.25 | 182.33 |
Goodwill | - | 345.87 | 315.3 | 315.23 | 315.23 |
Other Intangible Assets | - | 88.71 | 85.59 | 40.98 | 32.81 |
Long-Term Deferred Tax Assets | - | 3.8 | 22.69 | 33.65 | 30.27 |
Long-Term Deferred Charges | - | 32.49 | 45.58 | 26.17 | 22.74 |
Other Long-Term Assets | - | 29.19 | 11.88 | 10.26 | 6.87 |
Total Assets | - | 2,307 | 2,261 | 2,191 | 1,997 |
Accounts Payable | - | 58.44 | 26.69 | 28.06 | 20.25 |
Accrued Expenses | - | 56.08 | 79.24 | 126.02 | 122.59 |
Short-Term Debt | - | 15.25 | - | - | - |
Current Portion of Long-Term Debt | - | 8.5 | - | - | - |
Current Portion of Leases | - | 6.76 | 4.15 | 3.08 | 2.59 |
Current Income Taxes Payable | - | 1.46 | 1.09 | 12.81 | 13.67 |
Current Unearned Revenue | - | 6.23 | 4.74 | 9.73 | 10.7 |
Other Current Liabilities | - | 72.11 | 78.54 | 65.35 | 65.13 |
Total Current Liabilities | - | 224.84 | 194.45 | 245.05 | 234.92 |
Long-Term Debt | - | 8.38 | - | - | - |
Long-Term Leases | - | 8 | 0.83 | 2.3 | 2.49 |
Long-Term Unearned Revenue | - | 7.12 | 6.69 | 7.85 | 6.83 |
Pension & Post-Retirement Benefits | - | 1.64 | - | - | - |
Long-Term Deferred Tax Liabilities | - | 6.9 | 16.11 | 10.6 | 4.1 |
Other Long-Term Liabilities | - | 1.04 | 0.72 | 12.56 | 12.56 |
Total Liabilities | - | 257.91 | 218.8 | 278.35 | 260.9 |
Common Stock | - | 248.45 | 248.45 | 225.87 | 205.33 |
Additional Paid-In Capital | - | 1,016 | 1,012 | 1,035 | 1,055 |
Retained Earnings | - | 647.66 | 655.57 | 579.19 | 425.74 |
Comprehensive Income & Other | - | -0.52 | 0.1 | 0.04 | -0 |
Total Common Equity | 2,075 | 1,912 | 1,916 | 1,840 | 1,686 |
Minority Interest | - | 136.95 | 126.51 | 73.27 | 50.42 |
Shareholders' Equity | 2,096 | 2,049 | 2,043 | 1,913 | 1,736 |
Total Liabilities & Equity | - | 2,307 | 2,261 | 2,191 | 1,997 |
Total Debt | 43.6 | 46.9 | 4.99 | 5.39 | 5.07 |
Net Cash (Debt) | 512.89 | 641.26 | 669 | 528.15 | 753.86 |
Net Cash Growth | -20.02% | -4.15% | 26.67% | -29.94% | -34.05% |
Net Cash Per Share | 1.54 | 2.33 | 2.22 | 1.78 | 2.54 |
Filing Date Shares Outstanding | 353.76 | 333.46 | 298.14 | 298.14 | 298.14 |
Total Common Shares Outstanding | 333.46 | 298.14 | 298.14 | 298.14 | 298.14 |
Working Capital | - | 808.8 | 751.85 | 749.37 | 915.68 |
Book Value Per Share | 6.22 | 6.41 | 6.43 | 6.17 | 5.65 |
Tangible Book Value | 1,649 | 1,477 | 1,515 | 1,484 | 1,338 |
Tangible Book Value Per Share | 4.95 | 4.95 | 5.08 | 4.98 | 4.49 |
Buildings | - | 257.34 | 257.79 | 246.13 | 105.74 |
Machinery | - | 184.64 | 142.49 | 136.66 | 102.43 |
Construction In Progress | - | 5.46 | 6.53 | 4.62 | 100.06 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.